the economist glp 1 plan to rescue Novo Nordisk Could weight-loss drugs eat the

[14] showed that GLP-1RAs were associated with an increased risk of intestinal obstruction, compared to SGLT-2 inhibitors

This implies that DPP4is, characterized by their small molecular size (below 500 Da), can effectively hinder the enzyme's catalytic site, inhibiting its function, while preserving the molecule's capacity to act as a costimulatory factor without disruption

' Recommend appropriate monitoring (e.g., liver, thyroid, pulmonary assessment as clinically indicated)

by Nadia B

Supports overall daily wellness

Footnotes The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GAS declares potential conflict of interest as a research consultant to Wellcoaches